Rebalancing Controlled Substance Regulations in Telemedicine

Author:

Kannarkat Jacob T.1,Kannarkat Joseph T.2,Torous John3

Affiliation:

1. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

2. University of Maryland School of Medicine, Baltimore

3. Department of Psychiatry at Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Abstract

This Viewpoint elucidates major components of the proposed rules about controlled substance prescribing in telehealth, highlights evolving considerations with the US Drug Enforcement Agency’s approach, and offers potential improvements before finalization of the rules.

Publisher

American Medical Association (AMA)

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference9 articles.

1. Trends in mortality from alcohol, opioid, and combined alcohol and opioid poisonings by sex, educational attainment, and race and ethnicity for the United States 2000-2019.;Buckley;BMC Med,2022

2. How physician workforce shortages are hampering the response to the opioid crisis.;McNeely;Psychiatr Serv,2022

3. Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic.;Jones;JAMA Psychiatry,2022

4. Buprenorphine in the United States.;Chilcoat;J Subst Abuse Treat,2019

5. Telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation. Fed Regist.? 2023;88(40):12875-12890. Accessed March 26, 2023. https://www.federalregister.gov/d/2023-04248?

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3